Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Liu JS et al. – Addition of Haishengsu to the conventional immunotherapy is associated with an increased remission rate in patients with advanced renal cell cancer. Haishengsu was also associated with a reduced rate of gastrointestinal side–effects from the immunotherapeutic agents, and an improvement in the physical functionality of the patients.

Related Articles

Primary Renal Zygomycotic Infarction Mimicking Renal Neoplasia in an Immunocompetent Patient
The American Journal of the Medical Sciences, 10/20/09    Relevance Score: 64%

Childhood cancer mortality in Europe, 1970–2007
European Journal of Cancer, 10/14/09    Relevance Score: 64%

Clinical Characteristics of Renal Cell Carcinoma in Korean Patients with von Hippel-Lindau Disease Compared to Sporadic Bilateral or Multifocal Renal Cell Carcinoma
Journal of Korean Medical Science, 11/16/09    Relevance Score: 62%

The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09    Relevance Score: 47%

Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09    Relevance Score: 47%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address